Three letters in the pharma marketing vocabulary used to mean one thing: SEO. In 2026, brand teams now have to coordinate three optimisation disciplines, each with a different surface, a different unit of success and a different team owning it. They are SEO, GEO and AEO. They are related but not interchangeable, and the most expensive mistake pharma teams make in 2026 is treating GEO as a fancy name for SEO.
This guide gives precise definitions of all three terms, explains how they differ in practical pharma contexts, and shows the order in which a brand team should implement them.
What is SEO (Search Engine Optimization)?
SEO is the practice of structuring content so it ranks well in search engine results pages — the classical Google/Bing/Yahoo list of blue links. SEO has been the dominant pharma digital discipline for two decades. Its unit of success is the click: a user types a query, the search engine returns a ranked list of links, the user clicks. The discipline optimises title tags, meta descriptions, headings, internal linking, page speed, mobile usability, backlink authority, schema markup and content depth. In pharma, SEO is governed by MLR review of indexed content and by HCP/patient access gating where appropriate.
SEO still matters in 2026. Despite the noise about AI Overviews, classical organic search still drives the majority of brand-site sessions for most pharma brands. SEO is the foundation discipline; GEO and AEO build on top of it.
What is GEO (Generative Engine Optimization)?
GEO is the practice of measuring and improving how generative AI engines cite, rank and describe a brand inside the answer they generate. Generative engines — ChatGPT, Claude, Gemini, Perplexity, Mistral, Grok, Copilot, DeepSeek — do not return a list of links. They return a synthesised answer that may or may not contain links. GEO's unit of success is the citation: how often is the brand named, in what position, with what sentiment, citing which sources?
GEO is broader than SEO and operates on a different layer of the web. Where SEO ranks documents, GEO influences which documents become part of the generated answer. The discipline includes structured-data declaration (schema.org), claim-sentence front-loading (the first 30% of content drives ~44% of LLM citations, per the Princeton GEO study by Aggarwal et al., NeurIPS 2024), third-party source mix (society guidelines, PMC literature, specialist hubs, patient organisations), and cross-engine measurement.
For pharma specifically, GEO has to be MLR-compatible: the brand cannot generate content that would not pass promotional review, but it can structure existing approved content so AI engines retrieve it more reliably. Read the full primer on why pharma needs GEO in 2026.
What is AEO (Answer Engine Optimization)?
AEO is the practice of optimising for direct AI answer surfaces — Google AI Overviews, Bing Copilot answers, ChatGPT direct answers, Perplexity quick answers. AEO is a narrower discipline than GEO: where GEO covers any generative AI surface (including agent workflows, multi-turn conversations, AI-generated summaries inside enterprise tools), AEO focuses on the moment of direct answer generation.
AEO's unit of success is the snippet-style citation: the brand named in the synthesised answer paragraph itself, ideally with an inline citation to a brand-owned or brand-aligned source. AEO requires shorter, more declarative content patterns: explicit definitions, FAQ blocks with FAQPage schema, comparison tables in HTML (not images), and unambiguous claim sentences. Pharma AEO has a particular constraint: the answer box must not contain promotional language about an unapproved indication, even though the engine selects content the brand does not control.
How they differ — at a glance
| Dimension | SEO | GEO | AEO |
|---|---|---|---|
| Surface | SERP — ranked links | Any generative AI answer | Direct AI answer box |
| Unit of success | Click | Citation in answer | Citation in answer box |
| Engines | Google, Bing, Yahoo, DuckDuckGo | ChatGPT, Claude, Gemini, Perplexity, Mistral, Grok, Copilot, DeepSeek | AI Overviews, Copilot, ChatGPT answers, Perplexity quick answers |
| Primary lever | Title, meta, headings, backlinks | Source mix, claim sentences, schema | FAQ schema, tables, definitions |
| Measurement | Rank, CTR, sessions | Appearance rate, share of voice, citation diversity | Snippet capture rate, answer position |
| Pharma-specific risk | Off-label content in ranked pages | Off-label and PV signals inside synthesised answers | Boxed warnings and contraindications surfaced without context |
| Typical owner | Digital / Brand | Brand + Medical + Comms (cross-functional) | Digital + Medical Affairs |
Why pharma needs all three
The instinct of many brand teams in 2026 is to swap SEO for GEO. That is the wrong frame. Classical search is still the largest traffic driver for nearly every pharma brand site, and the SEO discipline is mature, MLR-tested and already integrated with brand governance. SEO does not go away.
At the same time, generative AI has become a primary information surface for both patients and HCPs. IQVIA's 2026 HCP study reports that 54% of HCPs now use generative AI tools in clinical contexts. See the full HCP AI search behaviour breakdown. A brand that is invisible in AI answers — or worse, that has competitors named first or that has off-label uses cited — is suffering a visibility loss that classical SEO analytics will never report.
AEO is the most specialised of the three, but it has the highest leverage per implementation effort. A single well-structured FAQPage with the right schema can capture an AI answer box for a high-volume disease-state query — and AI answer boxes typically reach more users than the equivalent rank-3 SERP position for the same query.
Practical pharma examples
SEO example. A brand site indication page ranks #2 on Google for "[brand] mechanism of action". The page is well-structured, has rich schema, fast load time, MLR-approved content. SEO tooling tells you this. Classical, well-understood.
GEO example. The same brand is named in only 47% of ChatGPT answers for the same disease state, while its main competitor is named in 89%. The brand does not control ChatGPT, but it does control which third-party society guidelines, PMC papers, patient organisation pages and specialist hubs reference its molecule. A 90-day GEO mobilisation can move the appearance rate from 47% to 80% by addressing source diversification, schema markup on the brand site, and structured Q&A content on independent third-party sites. See the 90-day pharma GEO mobilisation plan.
AEO example. A patient query "is [drug] safe in pregnancy" returns an AI Overview that cites a 2019 secondary source and surfaces a generic statement, while the FDA label has an updated 2025 boxed warning. AEO tactics — properly tagged Q&A blocks on the brand patient site, a clean FAQPage schema, an explicit definition sentence at the top of the page — can move that AI Overview to cite the brand's own MLR-approved patient FAQ alongside the FDA source.
The order of implementation
For a pharma brand starting from "we only do SEO":
- Baseline GEO measurement first. Run 80 prompts across at least three engines and two languages on your brand. You cannot prioritise GEO and AEO work without a baseline. Methodology here.
- SEO maintenance. Do not break what is working. Audit your existing SEO program for any gaps — schema, mobile, page speed, indexed PDFs that should be HTML.
- AEO upgrades on high-traffic indication pages. Add FAQPage schema, clean definition sentences, structured tables. AEO upgrades reuse existing MLR-approved content; they are low-risk, high-leverage.
- GEO source diversification. Work with medical affairs and communications to place MLR-approved content with society guidelines, PMC literature, specialist disease hubs and patient organisations. This is the slowest lever (4–8 weeks per source), but the highest-impact for engine citation.
- Cross-engine and cross-language monitoring. Engine divergence and language divergence are now the rule. Track each surface separately. See the six AI visibilities and engine divergence study.
Vocabulary glossary
For team alignment, here is a concise glossary your brand team can adopt as the controlled vocabulary:
- SEO (Search Engine Optimization) — discipline of ranking in classical search engine results pages.
- GEO (Generative Engine Optimization) — discipline of being cited in generative AI answers across any AI engine.
- AEO (Answer Engine Optimization) — subset of GEO targeting direct AI answer surfaces (AI Overviews, Copilot, ChatGPT direct answers).
- LLM SEO — informal synonym for GEO.
- AI visibility — overall measure of brand presence across AI answer surfaces. Composite of appearance rate, share of voice and citation quality.
- Appearance Rate (AR) — % of prompts in a defined set where the brand is mentioned by the engine.
- Share of Voice (SOV) — % of total brand mentions captured by a single brand across the prompt set.
- Citation diversity — number of independent source types citing the brand across an answer corpus.
- Engine divergence — the rank gap between two AI engines for the same brand and indication. Read more.
FAQ
What is GEO in pharma marketing?
GEO (Generative Engine Optimization) in pharma marketing is the practice of measuring and improving how generative AI engines cite, rank and describe a pharmaceutical brand. Unlike SEO, which targets ranked search results, GEO targets the synthesised AI answer.
What is the difference between GEO and AEO?
GEO is the broader discipline covering any generative AI engine. AEO is the narrower discipline focused on direct answer boxes (AI Overviews, ChatGPT direct answers, Copilot). AEO is best understood as a subset of GEO.
How is GEO different from SEO?
SEO targets ranked lists of links; GEO targets the AI-synthesised answer. SEO success is a click; GEO success is a citation inside an answer.
Why does pharma need a separate GEO program?
The AI answer layer surfaces safety information and competitive framing without brand control. MLR-approved owned content does not automatically appear in AI answers. A GEO program measures, governs and improves AI engine behaviour under regulatory constraints.
Which LLMs should pharma optimise for first?
ChatGPT, Perplexity, Google Gemini and Claude — in that order, based on consumer reach (ChatGPT), HCP and analyst reach with citations (Perplexity), Google search integration (Gemini), and enterprise rise (Claude).
Is AEO part of GEO or separate?
Most practitioners treat AEO as a subset of GEO focused on direct answer surfaces.
Do GEO and AEO replace SEO?
No. SEO still drives the majority of organic traffic for pharma brand sites in 2026. The three disciplines are complementary.
What is LLM SEO?
Informal synonym for GEO.
Want a real GEO and AEO audit on your brand? Request a sample report or get the full PharmaGEO Playbook.